Successful Combined Sequential Treatment with Two Bypassing Agents in a Hemophilia A Patient with High-Responding Inhibitor Induced Refractory Bleeding
Clinical & Experimental Thrombosis and Hemostasis · 2014
DOI: 10.14345/ceth.14009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Experimental Thrombosis and Hemostasis, 2014. Verfasst von Chen Chen Chu und 2 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Development of a persistent presence of anti-factor VIII/IX alloantibodies (inhibitors) when treated with coagulation FVIII/FIX concentrates is a serious complication of replacement therapy occurring in people with hemophilia. Two bypassing agents, activated prothrombin complex concentrate factor (aPCC) and recombinant coagulation factor VIIa (rFVIIa), are available and have been used successfully to control the bleeding episodes of patients with high-titer inhibitors. However when used independently, some bleeding episodes are found to be refractory to these two bypassing agents. A combination serial treatment with these two bypassing agents is currently used for controlling bleeding in patients with refractory bleeding episodes, along with cautious monitoring for thromboembolism and disseminated intravascular coagulation. We report a case of hemophilia A patient with a high-responding inhibitor in whom refractory bleeding occurred after orthopedic surgery, who was successfully treated with a sequential treatment with the two bypassing agents. Keywords: Hemophilia A, High-titer inhibitors, Sequential treatment, Bypassing agent
Zitieren
APA
Chu, C. C., Kim, J. Y., & You, C. W. (2014). Successful Combined Sequential Treatment with Two Bypassing Agents in a Hemophilia A Patient with High-Responding Inhibitor Induced Refractory Bleeding. Clinical & Experimental Thrombosis and Hemostasis. https://doi.org/10.14345/ceth.14009
Vancouver
Chu CC, Kim JY, You CW. Successful Combined Sequential Treatment with Two Bypassing Agents in a Hemophilia A Patient with High-Responding Inhibitor Induced Refractory Bleeding. Clinical & Experimental Thrombosis and Hemostasis. 2014. doi:10.14345/ceth.14009
BibTeX
@article{Chu2014,
author = {Chu, Chen Chen and Kim, Ju Young and You, Chur Woo},
title = {Successful Combined Sequential Treatment with Two Bypassing Agents in a Hemophilia A Patient with High-Responding Inhibitor Induced Refractory Bleeding},
journal = {Clinical & Experimental Thrombosis and Hemostasis},
year = {2014},
doi = {10.14345/ceth.14009}
}
EUVIMED